Bassetlaw MP Jo White shared her 30-year struggle with endometriosis, urging the NHS to prioritize diagnosis and treatment for the condition affecting 1 in 10 UK women. She welcomed revised NICE guidelines for quicker referrals and scanning.
Endometriosis diagnoses in Rhineland-Palatinate have increased by 82% over 20 years, reaching approximately 22,500 cases in 2024. Increased societal awareness is cited as a key reason for the rise, reducing diagnostic uncertainty for affected women.
Australia's One Nation party faces scrutiny over 'sloppy' financial reports with over $1m in missing assets. US President Trump accuses Iran of 'playing us for suckers' amid imminent strike threats. Thousands of Australian women face medicine uncertainty, while World Cup predictions begin.
AstraZeneca will remove the Goserelin 3.6mg implant (Zoladex) from Australia's Pharmaceutical Benefits Scheme and private market in November due to commercial reasons, impacting thousands of breast cancer and endometriosis patients. A higher dose for prostate cancer will remain.
Endometriosis, a debilitating inflammatory disease affecting 1 in 10 women, is a "silent medical emergency" that demands urgent attention. The article highlights the severe pain, long diagnostic delays (average 9+ years in the UK), and limited treatment options, forcing women like Chloe to consider hysterectomy at 26.
A pilot study at Oxford University has developed a new CT scan technique using a molecular tracer called maraciclatide that can detect early-stage endometriosis, which standard scans often miss. The technique correctly identified endometriosis in 16 of 19 participants and 14 of 17 surgically confirmed cases. Endometriosis affects one in 10 women in the UK but currently takes an average of nine years to diagnose, with the only definitive diagnosis method being invasive laparoscopy surgery.
A pilot study at Oxford University has developed a new CT scan technique using a molecular tracer called maraciclatide that can detect early endometriosis, which is often missed by conventional scans. The technique correctly identified endometriosis in 16 out of 19 participants and picked up 14 of 17 cases later confirmed by surgery. Endometriosis affects one in 10 women in the UK but currently takes an average of nine years to diagnose, with standard ultrasounds and MRIs often failing to detect the early stages of the condition.
A trial at the University of Oxford has shown that an experimental radiotracer called maraciclatide can successfully detect endometriosis through a non-invasive scan. The study of 19 women found the scan aligned with surgical diagnosis in 16 cases with no false positives. Currently, women in England wait an average of 9 years 4 months for diagnosis, which requires invasive surgery. If confirmed in larger trials, the scan could transform diagnosis and treatment of this condition affecting one in 10 women.
